CD4 and AIDS: Viro-immunological characteristics of the PLWH group were the following: median CD4+ cells count at COVID-19 diagnosis: 272 cells/μL (IQR127–468); median CD4+ cells count at lowest point: 185 cells/μL (IQR75–322); 32% with a previous diagnosis of AIDS, all had antiretroviral therapy; and 77% had HIV-1 RNA < 50 copies/mL at COVID-19 diagnosis.